DCTN5 Antibody / Dynactin subunit 5 Antibody (FY13656)

DCTN5 Antibody by IHC in Human Pancreatic Cancer Tissue. Immunohistochemistry analysis of DCTN5 expression in a paraffin-embedded section of human pancreatic cancer tissue using DCTN5 Antibody. Brown DAB staining is prominent in the cytoplasm of malignant epithelial cells, with variable intensity across the tumor. Hematoxylin counterstaining highlights the nuclei, while adjacent connective tissue shows comparatively weaker immunoreactivity. The staining pattern demonstrates DCTN5 detection in the examined pancreatic tumor section.

DCTN5 Antibody by IHC in Human Liver Cancer Tissue. Immunohistochemistry analysis of DCTN5 expression in a paraffin-embedded section of human liver cancer tissue using DCTN5 Antibody. Strong brown DAB staining is visible throughout numerous tumor cells, predominantly in the cytoplasm. The staining is heterogeneous, with variable intensity among individual cells. Nuclei are counterstained blue with hematoxylin, and the surrounding stromal regions exhibit comparatively limited immunoreactivity.

DCTN5 Antibody by WB in six human cell lines. Western blot analysis of MCF-7, SH-SY5Y, HepG2, K562, PC-12 and Neuro-2a lysates, shown in lanes 1-6, respectively, using DCTN5 Antibody. Immunoreactive bands are visible predominantly near 15-16 kDa, with a faint signal near 20 kDa in selected samples. The observed major bands are consistent with the expected low molecular weight of dynactin subunit 5. Signal intensity varies among the lysates. The blot includes a molecular weight marker at left; no identity is assigned to additional weak signals without independent validation.